Skip to content

Analysis of oral and intestinal microbiota composition in hypertriglyceridemic acute pancreatitis

Analysis of oral and intestinal microbiota composition in hypertriglyceridemic acute pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096170
Enrollment
Unknown
Registered
2025-01-20
Start date
2025-01-24
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertriglyceridemic acute pancreatitis

Interventions

Sponsors

Zhongshan Hospital, Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria for hyperlipidemic pancreatitis:abdominal pain consistent with the onset, elevated serum amylase and/or lipase levels>= 3 times the upper limit of normal, and imaging findings consistent with changes in pancreatitis (CT, MRI, ultrasound). (2) Triglyceride levels >= 11.3mmol/L, or triglycerides 5.65 ~ 11.3mmol/L, but with a chyle like appearance in the serum. (3) Simultaneously comply with Article 1 and Article 2, and exclude other causes of acute pancreatitis such as biliary tract disease, alcohol, trauma, tumors, etc. 2.Admitted within 48 hours of symptom onset (calculated based on the onset of abdominal pain); 3.Age>18 years old and signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with chronic pancreatitis; Tumor patients; Patients with serious heart, brain, liver, kidney, immune system disease, mental disease, infectious diseases; Serious oral diseases, received oral treatment within the past six months; Previous history of abdominal surgery; 2.Admitted within 48 hours of onset; 3.Age<18 years old; 4.Pregnant and lactating women; 5.Use of antibiotics, hormones, immunosuppressants, probiotics and/or prebiotics, PPI preparations in the past month; 6.Those who have not signed informed consent and have given up treatment.

Design outcomes

Primary

MeasureTime frame
triglyceride;Microbial community diversity;Specific microbial markers;

Countries

China

Contacts

Public ContactLin Zhenhe

Zhongshan Hospital, Xiamen University

zhenhelin@163.com+86 136 0097 8751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026